Snowball logo
logo
6007

NanJing Pharmaceutical Co Ltd

600713 SHG
¥5.30¥0.00  (0%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
45,123.250,221.653,589.753,696.254,963.354,560.2
COGS
42,189.746,969.250,282.650,341.351,580.951,157.8
Gross Profit
2,933.53,252.43,307.13,354.83,382.33,402.4
Operating Expenses & Income
Operating Income
845.7934.31,007.41,023.41,533.61,250.5
Total Operating Expenses
2,087.82,318.12,299.62,331.453,429.728,019.1
R&D Expenses
20.9627.4336.1930.6446.7945.29
Selling General & Admin Expenses
432.9487.1517.4517.7492.4(68)
Earnings from Continuing Operations
Interest Expense
(455)(446.6)(544.9)(529.2)(309)(304.4)
Interest Income
13.1711.4110.1413.6120.6413.05
Income Tax Expense
228.3190.1265.3260.3-118
Net Income
Net Income
505.2595.7577.8570.6624.8622
Supplemental
EBIT
1,293.91,352.61,5231,532.6--
EBITDA
1,441.21,506.41,676.71,669.1--
In millions of CNY, except % and values per 1 share